ResearcherNanjing Medical UniversityNo recent work listed

Bin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3544-5056; OpenAlex author ID A5100427330. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper

Papers 1

miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. Co-author DOI 10.3892/mmr.2018.8941 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ying Xin · 1 shared paper, 2018 · strength 0.08
- Paper miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. DOI 10.3892/mmr.2018.8941 ↗
Yunpeng Peng · 1 shared paper, 2018 · strength 0.08
- Paper miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. DOI 10.3892/mmr.2018.8941 ↗
Jishu Wei · 1 shared paper, 2018 · strength 0.08
- Paper miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. DOI 10.3892/mmr.2018.8941 ↗
Yi Miao · 1 shared paper, 2018 · strength 0.08
- Paper miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. DOI 10.3892/mmr.2018.8941 ↗
Xinchun Liu · 1 shared paper, 2018 · strength 0.08
- Paper miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. DOI 10.3892/mmr.2018.8941 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.